Clinical Trial

The Effect of LDL557 on Improving Degenerative Arthritis in the Elderly

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated September 30, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This project is to conduct a clinical trial of SYNBIO TECH INC.'s LDL557 capsule for joint protection. To understand the improvement of joint discomfort and inflammation after supplementation, we hope to provide an updated choice for modern people's joint protection.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-23.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-09-24
Trial Details
NCT Number NCT06658821
Lead Sponsor Chung Shan Medical University
Collaborators: SYNBIO TECH INC. Kaohsiung Taiwan
Conditions Arthritis, Joint Pain
Enrollment 100 participants
Start Date 2025-02-27
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-30